ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cytomegalovirus (CMV) Vaccine Market Research Report 2025
Published Date: July 2025
|
Report Code: QYRE-Auto-19O10054
Home | Market Reports | Health| Health Conditions| Infectious Diseases
Global Cytomegalovirus CMV Vaccine Market Insights Forecast to 2028
BUY CHAPTERS

Global Cytomegalovirus (CMV) Vaccine Market Research Report 2025

Code: QYRE-Auto-19O10054
Report
July 2025
Pages:76
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Merck
AlphaVax
Moderna, Inc
Novartis

Cytomegalovirus (CMV) Vaccine Market Size

The global market for Cytomegalovirus (CMV) Vaccine was valued at US$ 165 million in the year 2024 and is projected to reach a revised size of US$ 223 million by 2031, growing at a CAGR of 4.4% during the forecast period.

Cytomegalovirus (CMV) Vaccine Market

Cytomegalovirus (CMV) Vaccine Market

Cytomegalovirus (CMV) also known as HCMV, or Human Herpesvirus 5 (HHV-5) is the virus most commonly transmitted to a developing fetus. It is a common virus that infects people of all ages. According to the CDC, over half of adults by age 40 have been infected with CMV. Most people infected with CMV show no signs or symptoms. Whereas when a baby is born with cytomegalovirus (CMV) infection, it is called congenital CMV. Each year, approximately 5,000 infants in the U.S. may develop permanent problems due to CMV, some of the severe problems, includes deafness, blindness, and mental retardation. Furthermore, the global prevalence of congenital cytomegalovirus is said to be 0.3 – 2.0%. The Institute of Medicine (IOM) of the National Academy of Sciences, has designated CMV as a “highest priority” category for vaccine development, citing the years of life and disability that could be saved.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cytomegalovirus (CMV) Vaccine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cytomegalovirus (CMV) Vaccine.
The Cytomegalovirus (CMV) Vaccine market size, estimations, and forecasts are provided in terms of sales volume (K Doses) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cytomegalovirus (CMV) Vaccine market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cytomegalovirus (CMV) Vaccine manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cytomegalovirus (CMV) Vaccine Market Report

Report Metric Details
Report Name Cytomegalovirus (CMV) Vaccine Market
Accounted market size in year US$ 165 million
Forecasted market size in 2031 US$ 223 million
CAGR 4.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Merck, AlphaVax, Moderna, Novartis
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cytomegalovirus (CMV) Vaccine manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cytomegalovirus (CMV) Vaccine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

How fast is Cytomegalovirus (CMV) Vaccine Market growing?

Ans: The Cytomegalovirus (CMV) Vaccine Market witnessing a CAGR of 4.4% during the forecast period 2025-2031.

What is the Cytomegalovirus (CMV) Vaccine Market size in 2031?

Ans: The Cytomegalovirus (CMV) Vaccine Market size in 2031 will be US$ 223 million.

Who are the main players in the Cytomegalovirus (CMV) Vaccine Market report?

Ans: The main players in the Cytomegalovirus (CMV) Vaccine Market are Merck, AlphaVax, Moderna, Novartis

What are the Application segmentation covered in the Cytomegalovirus (CMV) Vaccine Market report?

Ans: The Applications covered in the Cytomegalovirus (CMV) Vaccine Market report are Laboratories, Hospitals, Diagnostic Centers and Clinics, Others

What are the Type segmentation covered in the Cytomegalovirus (CMV) Vaccine Market report?

Ans: The Types covered in the Cytomegalovirus (CMV) Vaccine Market report are Attenuated Vaccines, Subunit Vaccines

Recommended Reports

Vaccine Markets

Infection & Disease

Flu & Viral Vaccines

1 Cytomegalovirus (CMV) Vaccine Market Overview
1.1 Product Definition
1.2 Cytomegalovirus (CMV) Vaccine by Type
1.2.1 Global Cytomegalovirus (CMV) Vaccine Market Value Comparison by Type (2024 VS 2031)
1.2.2 Attenuated Vaccines
1.2.3 Subunit Vaccines
1.3 Cytomegalovirus (CMV) Vaccine by Application
1.3.1 Global Cytomegalovirus (CMV) Vaccine Market Value by Application (2024 VS 2031)
1.3.2 Laboratories
1.3.3 Hospitals
1.3.4 Diagnostic Centers and Clinics
1.3.5 Others
1.4 Global Cytomegalovirus (CMV) Vaccine Market Size Estimates and Forecasts
1.4.1 Global Cytomegalovirus (CMV) Vaccine Revenue 2020-2031
1.4.2 Global Cytomegalovirus (CMV) Vaccine Sales 2020-2031
1.4.3 Global Cytomegalovirus (CMV) Vaccine Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cytomegalovirus (CMV) Vaccine Market Competition by Manufacturers
2.1 Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cytomegalovirus (CMV) Vaccine Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cytomegalovirus (CMV) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Product Type & Application
2.7 Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Date of Enter into This Industry
2.8 Global Cytomegalovirus (CMV) Vaccine Market Competitive Situation and Trends
2.8.1 Global Cytomegalovirus (CMV) Vaccine Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cytomegalovirus (CMV) Vaccine Players Market Share by Revenue
2.8.3 Global Cytomegalovirus (CMV) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cytomegalovirus (CMV) Vaccine Market Scenario by Region
3.1 Global Cytomegalovirus (CMV) Vaccine Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cytomegalovirus (CMV) Vaccine Sales by Region: 2020-2031
3.2.1 Global Cytomegalovirus (CMV) Vaccine Sales by Region: 2020-2025
3.2.2 Global Cytomegalovirus (CMV) Vaccine Sales by Region: 2026-2031
3.3 Global Cytomegalovirus (CMV) Vaccine Revenue by Region: 2020-2031
3.3.1 Global Cytomegalovirus (CMV) Vaccine Revenue by Region: 2020-2025
3.3.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Region: 2026-2031
3.4 North America Cytomegalovirus (CMV) Vaccine Market Facts & Figures by Country
3.4.1 North America Cytomegalovirus (CMV) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cytomegalovirus (CMV) Vaccine Sales by Country (2020-2031)
3.4.3 North America Cytomegalovirus (CMV) Vaccine Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cytomegalovirus (CMV) Vaccine Market Facts & Figures by Country
3.5.1 Europe Cytomegalovirus (CMV) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cytomegalovirus (CMV) Vaccine Sales by Country (2020-2031)
3.5.3 Europe Cytomegalovirus (CMV) Vaccine Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cytomegalovirus (CMV) Vaccine Market Facts & Figures by Region
3.6.1 Asia Pacific Cytomegalovirus (CMV) Vaccine Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cytomegalovirus (CMV) Vaccine Sales by Region (2020-2031)
3.6.3 Asia Pacific Cytomegalovirus (CMV) Vaccine Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Cytomegalovirus (CMV) Vaccine Market Facts & Figures by Country
3.7.1 Latin America Cytomegalovirus (CMV) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cytomegalovirus (CMV) Vaccine Sales by Country (2020-2031)
3.7.3 Latin America Cytomegalovirus (CMV) Vaccine Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Facts & Figures by Country
3.8.1 Middle East and Africa Cytomegalovirus (CMV) Vaccine Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cytomegalovirus (CMV) Vaccine Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cytomegalovirus (CMV) Vaccine Sales by Type (2020-2031)
4.1.1 Global Cytomegalovirus (CMV) Vaccine Sales by Type (2020-2025)
4.1.2 Global Cytomegalovirus (CMV) Vaccine Sales by Type (2026-2031)
4.1.3 Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2020-2031)
4.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Type (2020-2031)
4.2.1 Global Cytomegalovirus (CMV) Vaccine Revenue by Type (2020-2025)
4.2.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Type (2026-2031)
4.2.3 Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2020-2031)
4.3 Global Cytomegalovirus (CMV) Vaccine Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cytomegalovirus (CMV) Vaccine Sales by Application (2020-2031)
5.1.1 Global Cytomegalovirus (CMV) Vaccine Sales by Application (2020-2025)
5.1.2 Global Cytomegalovirus (CMV) Vaccine Sales by Application (2026-2031)
5.1.3 Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2020-2031)
5.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Application (2020-2031)
5.2.1 Global Cytomegalovirus (CMV) Vaccine Revenue by Application (2020-2025)
5.2.2 Global Cytomegalovirus (CMV) Vaccine Revenue by Application (2026-2031)
5.2.3 Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2020-2031)
5.3 Global Cytomegalovirus (CMV) Vaccine Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Merck
6.1.1 Merck Company Information
6.1.2 Merck Description and Business Overview
6.1.3 Merck Cytomegalovirus (CMV) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Merck Cytomegalovirus (CMV) Vaccine Product Portfolio
6.1.5 Merck Recent Developments/Updates
6.2 AlphaVax
6.2.1 AlphaVax Company Information
6.2.2 AlphaVax Description and Business Overview
6.2.3 AlphaVax Cytomegalovirus (CMV) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.2.4 AlphaVax Cytomegalovirus (CMV) Vaccine Product Portfolio
6.2.5 AlphaVax Recent Developments/Updates
6.3 Moderna
6.3.1 Moderna Company Information
6.3.2 Moderna Description and Business Overview
6.3.3 Moderna Cytomegalovirus (CMV) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.3.4 Moderna Cytomegalovirus (CMV) Vaccine Product Portfolio
6.3.5 Moderna Recent Developments/Updates
6.4 Novartis
6.4.1 Novartis Company Information
6.4.2 Novartis Description and Business Overview
6.4.3 Novartis Cytomegalovirus (CMV) Vaccine Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Novartis Cytomegalovirus (CMV) Vaccine Product Portfolio
6.4.5 Novartis Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cytomegalovirus (CMV) Vaccine Industry Chain Analysis
7.2 Cytomegalovirus (CMV) Vaccine Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cytomegalovirus (CMV) Vaccine Production Mode & Process Analysis
7.4 Cytomegalovirus (CMV) Vaccine Sales and Marketing
7.4.1 Cytomegalovirus (CMV) Vaccine Sales Channels
7.4.2 Cytomegalovirus (CMV) Vaccine Distributors
7.5 Cytomegalovirus (CMV) Vaccine Customer Analysis
8 Cytomegalovirus (CMV) Vaccine Market Dynamics
8.1 Cytomegalovirus (CMV) Vaccine Industry Trends
8.2 Cytomegalovirus (CMV) Vaccine Market Drivers
8.3 Cytomegalovirus (CMV) Vaccine Market Challenges
8.4 Cytomegalovirus (CMV) Vaccine Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Merck
AlphaVax
Moderna, Inc
Novartis
List of Tables
 Table 1. Global Cytomegalovirus (CMV) Vaccine Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cytomegalovirus (CMV) Vaccine Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cytomegalovirus (CMV) Vaccine Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cytomegalovirus (CMV) Vaccine Sales (K Doses) of Key Manufacturers (2020-2025)
 Table 5. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cytomegalovirus (CMV) Vaccine Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cytomegalovirus (CMV) Vaccine Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cytomegalovirus (CMV) Vaccine Average Price (US$/Dose) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cytomegalovirus (CMV) Vaccine, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Product Type & Application
 Table 12. Global Key Manufacturers of Cytomegalovirus (CMV) Vaccine, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cytomegalovirus (CMV) Vaccine by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cytomegalovirus (CMV) Vaccine as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cytomegalovirus (CMV) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cytomegalovirus (CMV) Vaccine Sales by Region (2020-2025) & (K Doses)
 Table 18. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Region (2020-2025)
 Table 19. Global Cytomegalovirus (CMV) Vaccine Sales by Region (2026-2031) & (K Doses)
 Table 20. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Region (2026-2031)
 Table 21. Global Cytomegalovirus (CMV) Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Region (2020-2025)
 Table 23. Global Cytomegalovirus (CMV) Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Region (2026-2031)
 Table 25. North America Cytomegalovirus (CMV) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cytomegalovirus (CMV) Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 27. North America Cytomegalovirus (CMV) Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 28. North America Cytomegalovirus (CMV) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cytomegalovirus (CMV) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cytomegalovirus (CMV) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cytomegalovirus (CMV) Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 32. Europe Cytomegalovirus (CMV) Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 33. Europe Cytomegalovirus (CMV) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cytomegalovirus (CMV) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cytomegalovirus (CMV) Vaccine Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cytomegalovirus (CMV) Vaccine Sales by Region (2020-2025) & (K Doses)
 Table 37. Asia Pacific Cytomegalovirus (CMV) Vaccine Sales by Region (2026-2031) & (K Doses)
 Table 38. Asia Pacific Cytomegalovirus (CMV) Vaccine Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cytomegalovirus (CMV) Vaccine Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cytomegalovirus (CMV) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cytomegalovirus (CMV) Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 42. Latin America Cytomegalovirus (CMV) Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 43. Latin America Cytomegalovirus (CMV) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cytomegalovirus (CMV) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cytomegalovirus (CMV) Vaccine Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Country (2020-2025) & (K Doses)
 Table 47. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales by Country (2026-2031) & (K Doses)
 Table 48. Middle East and Africa Cytomegalovirus (CMV) Vaccine Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cytomegalovirus (CMV) Vaccine Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cytomegalovirus (CMV) Vaccine Sales (K Doses) by Type (2020-2025)
 Table 51. Global Cytomegalovirus (CMV) Vaccine Sales (K Doses) by Type (2026-2031)
 Table 52. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2020-2025)
 Table 53. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Type (2026-2031)
 Table 54. Global Cytomegalovirus (CMV) Vaccine Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cytomegalovirus (CMV) Vaccine Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2020-2025)
 Table 57. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Type (2026-2031)
 Table 58. Global Cytomegalovirus (CMV) Vaccine Price (US$/Dose) by Type (2020-2025)
 Table 59. Global Cytomegalovirus (CMV) Vaccine Price (US$/Dose) by Type (2026-2031)
 Table 60. Global Cytomegalovirus (CMV) Vaccine Sales (K Doses) by Application (2020-2025)
 Table 61. Global Cytomegalovirus (CMV) Vaccine Sales (K Doses) by Application (2026-2031)
 Table 62. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2020-2025)
 Table 63. Global Cytomegalovirus (CMV) Vaccine Sales Market Share by Application (2026-2031)
 Table 64. Global Cytomegalovirus (CMV) Vaccine Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cytomegalovirus (CMV) Vaccine Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2020-2025)
 Table 67. Global Cytomegalovirus (CMV) Vaccine Revenue Market Share by Application (2026-2031)
 Table 68. Global Cytomegalovirus (CMV) Vaccine Price (US$/Dose) by Application (2020-2025)
 Table 69. Global Cytomegalovirus (CMV) Vaccine Price (US$/Dose) by Application (2026-2031)
 Table 70. Merck Company Information
 Table 71. Merck Description and Business Overview
 Table 72. Merck Cytomegalovirus (CMV) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 73. Merck Cytomegalovirus (CMV) Vaccine Product
 Table 74. Merck Recent Developments/Updates
 Table 75. AlphaVax Company Information
 Table 76. AlphaVax Description and Business Overview
 Table 77. AlphaVax Cytomegalovirus (CMV) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 78. AlphaVax Cytomegalovirus (CMV) Vaccine Product
 Table 79. AlphaVax Recent Developments/Updates
 Table 80. Moderna Company Information
 Table 81. Moderna Description and Business Overview
 Table 82. Moderna Cytomegalovirus (CMV) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 83. Moderna Cytomegalovirus (CMV) Vaccine Product
 Table 84. Moderna Recent Developments/Updates
 Table 85. Novartis Company Information
 Table 86. Novartis Description and Business Overview
 Table 87. Novartis Cytomegalovirus (CMV) Vaccine Sales (K Doses), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 88. Novartis Cytomegalovirus (CMV) Vaccine Product
 Table 89. Novartis Recent Developments/Updates
 Table 90. Key Raw Materials Lists
 Table 91. Raw Materials Key Suppliers Lists
 Table 92. Cytomegalovirus (CMV) Vaccine Distributors List
 Table 93. Cytomegalovirus (CMV) Vaccine Customers List
 Table 94. Cytomegalovirus (CMV) Vaccine Market Trends
 Table 95. Cytomegalovirus (CMV) Vaccine Market Drivers
 Table 96. Cytomegalovirus (CMV) Vaccine Market Challenges
 Table 97. Cytomegalovirus (CMV) Vaccine Market Restraints
 Table 98. Research Programs/Design for This Report
 Table 99. Key Data Information from Secondary Sources
 Table 100. Key Data Information from Primary Sources
 Table 101. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cytomegalovirus (CMV) Vaccine
 Figure 2. Global Cytomegalovirus (CMV) Vaccine Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cytomegalovirus (CMV) Vaccine Market Share by Type: 2024 & 2031
 Figure 4. Attenuated Vaccines Product Picture
 Figure 5. Subunit Vaccines Product Picture
 Figure 6. Global Cytomegalovirus (CMV) Vaccine Market Value by Application (2020-2031) & (US$ Million)
 Figure 7. Global Cytomegalovirus (CMV) Vaccine Market Share by Application: 2024 & 2031
 Figure 8. Laboratories
 Figure 9. Hospitals
 Figure 10. Diagnostic Centers and Clinics
 Figure 11. Others
 Figure 12. Global Cytomegalovirus (CMV) Vaccine Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 13. Global Cytomegalovirus (CMV) Vaccine Market Size (2020-2031) & (US$ Million)
 Figure 14. Global Cytomegalovirus (CMV) Vaccine Sales (2020-2031) & (K Doses)
 Figure 15. Global Cytomegalovirus (CMV) Vaccine Average Price (US$/Dose) & (2020-2031)
 Figure 16. Cytomegalovirus (CMV) Vaccine Report Years Considered
 Figure 17. Cytomegalovirus (CMV) Vaccine Sales Share by Manufacturers in 2024
 Figure 18. Global Cytomegalovirus (CMV) Vaccine Revenue Share by Manufacturers in 2024
 Figure 19. Global 5 and 10 Largest Cytomegalovirus (CMV) Vaccine Players: Market Share by Revenue in Cytomegalovirus (CMV) Vaccine in 2024
 Figure 20. Cytomegalovirus (CMV) Vaccine Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 21. Global Cytomegalovirus (CMV) Vaccine Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 22. North America Cytomegalovirus (CMV) Vaccine Sales Market Share by Country (2020-2031)
 Figure 23. North America Cytomegalovirus (CMV) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 24. United States Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 25. Canada Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Europe Cytomegalovirus (CMV) Vaccine Sales Market Share by Country (2020-2031)
 Figure 27. Europe Cytomegalovirus (CMV) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 28. Germany Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 29. France Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. U.K. Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. Italy Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Russia Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Asia Pacific Cytomegalovirus (CMV) Vaccine Sales Market Share by Region (2020-2031)
 Figure 34. Asia Pacific Cytomegalovirus (CMV) Vaccine Revenue Market Share by Region (2020-2031)
 Figure 35. China Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 36. Japan Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. South Korea Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. India Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. Australia Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. China Taiwan Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. Indonesia Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Thailand Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Malaysia Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 44. Latin America Cytomegalovirus (CMV) Vaccine Sales Market Share by Country (2020-2031)
 Figure 45. Latin America Cytomegalovirus (CMV) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 46. Mexico Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Brazil Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Argentina Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 49. Middle East and Africa Cytomegalovirus (CMV) Vaccine Sales Market Share by Country (2020-2031)
 Figure 50. Middle East and Africa Cytomegalovirus (CMV) Vaccine Revenue Market Share by Country (2020-2031)
 Figure 51. Turkey Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. Saudi Arabia Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. UAE Cytomegalovirus (CMV) Vaccine Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 54. Global Sales Market Share of Cytomegalovirus (CMV) Vaccine by Type (2020-2031)
 Figure 55. Global Revenue Market Share of Cytomegalovirus (CMV) Vaccine by Type (2020-2031)
 Figure 56. Global Cytomegalovirus (CMV) Vaccine Price (US$/Dose) by Type (2020-2031)
 Figure 57. Global Sales Market Share of Cytomegalovirus (CMV) Vaccine by Application (2020-2031)
 Figure 58. Global Revenue Market Share of Cytomegalovirus (CMV) Vaccine by Application (2020-2031)
 Figure 59. Global Cytomegalovirus (CMV) Vaccine Price (US$/Dose) by Application (2020-2031)
 Figure 60. Cytomegalovirus (CMV) Vaccine Value Chain
 Figure 61. Channels of Distribution (Direct Vs Distribution)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Seventh Sense AI

SIMILAR REPORTS

Global Cytomegalovirus Infection Market Research Report 2024
Global Cytomegalovirus CMV Treatment Drugs Market Research Report 2024
Cytomegalovirus IgM Detection Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cytomegalovirus CMV Diagnostic Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cytomegalovirus Treatment Market Research Report 2024
Global Human Papillomavirus and Cytomegalovirus Therapeutics Market Research Report 2024
Global Cytomegalovirus Disease Treatments Market Research Report 2024
Global Cytomegalovirus HHV 5 Infection Therapeutic Drugs Market Insights Forecast to 2030
Global Cytomegalovirus Retinitis Treatment Market Research Report 2024
Cytomegalovirus Therapeutics Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cytomegalovirus Immune Globulin Intravenous Human CMV IGIV Market Research Report 2024
Global Cytomegalovirus ELISA Kits Market Research Report 2024
Global Cytomegalovirus Assay Market Research Report 2024
Global Human Cytomegalovirus Envelope Glycoprotein B Market Research Report 2025
Global Human Cytomegalovirus Detection Kit Market Research Report 2024
Global Valganciclovir Hcl API Market Research Report 2025
Global Varicella Vaccine Sales Market Report Competitive Analysis and Regional Opportunities 2025 2031
Global EB Virus Nucleic Acid PCR Detection Kits Market Research Report 2024
Global Herpes Simplex Virus HSV Vaccines Market Insights Forecast to 2030
Global Chick Embryo Cell Rabies Vaccine Market Research Report 2024

RELATED REPORTS

Global Hepatitis B Virus Core Antibody Diagnostic Kits Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-21N6899
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Pediatric Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-13M6952
Wed Sep 10 00:00:00 UTC 2025

Add to Cart

Global Poliomyelitis Vaccines Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-29X7355
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Global Varicella Virus (Chickenpox) Vaccine Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-28B293
Tue Sep 09 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions